innoscripta Rebounds 9% as Investors Weigh Tax Probe Against Intact Operations

innoscripta shares fell 52% over seven days after Munich office raids over research grant tax allegations, then rebounded 9.0% to EUR 41.05.

Munich-based tax advisory firm innoscripta found itself thrust into the spotlight last week when investigators searched its offices in Munich and Tutzing, sending the stock to a fresh 52-week low of EUR 31.05 during Thursday's session. The raids, carried out under two orders issued by the Amtsgericht Schwäbisch Gmünd, stem from suspicions that the company aided clients in obtaining unjustified tax benefits tied to research grants.

The market's response was swift and severe. Over a seven-day stretch, the shares shed 52 percent of their value as risk aversion gripped investors confronted with tax-law allegations against a business built on regulatory compliance. Yet by Friday's close, the stock had clawed back ground, settling at EUR 41.05 for a daily gain of 9.0 percent. Whether that bounce can be attributed to the company's damage-control statement remains unconfirmed, according to media reports.

Management Strikes a Defiant Tone

innoscripta moved quickly to reassure shareholders. CEO Michael Hohenester said the company is cooperating fully with investigators, and management stressed that no transactions from the current 2026 fiscal year are implicated in the probe based on present information. Regular business operations, the company insists, continue without interruption.

Two arguments underpin the firm's defense. First, the allegations center on an employee who left innoscripta several years ago. Second, the company points to the thousands of grant decisions already confirmed by tax authorities and validated in numerous client audits — a track record it says demonstrates the soundness of its advisory model.

The Mechanics Behind the Revenue Model

Understanding the stakes requires a look at how innoscripta earns its fees. The process unfolds in two stages: the Bescheinigungsstelle Forschungszulage first assesses whether a project qualifies for funding, after which the client's local tax office sets the specific allowance. Crucially, innoscripta's fee is almost always triggered the moment the certification body issues its decision.

That timing makes the durability of those administrative rulings the pivotal unknown for investors. If only individual clients' funding is called into question, the damage stays contained. Should the underlying approval practices themselves come under scrutiny, however, historical revenue could be at risk.

Reputation Is the Real Battleground

The looming threat for the months ahead is less about legal outcomes than about client confidence. Tax incentive schemes depend heavily on trust, and news of office raids could give prospective customers pause before filing new applications. A slowdown in new business would weigh meaningfully on growth momentum.

Regulatory tax investigations also tend to drag on, clouding valuation for as long as the Amtsgericht Schwäbisch Gmünd has yet to resolve the matter. Even if fiscal 2026 escapes operational damage, reputational fallout could complicate client acquisition. Potential clawbacks or follow-up audits remain live risks until the case is closed.

A Product Launch Becomes the Next Test

For now, the stock has room to stabilize provided the investigation stays confined to past dealings and no impact on the current year emerges. Any expansion of the probe into newer projects — or complaints from additional clients — could reignite selling pressure.

The next concrete catalyst is a product presentation to which the company has invited its shareholders. Management will have the chance to demonstrate the strength of its technology and, more importantly, to shift attention from legal legacies back to operational progress. A friendly gesture of goodwill, to be sure — but no substitute for regulatory all-clear. Until innoscripta proves its controls are airtight and the incident genuinely isolated, the episode stands as a case study in how exposed service providers in the subsidy space are to reputational risk.